0000873303-14-000030.txt : 20140304 0000873303-14-000030.hdr.sgml : 20140304 20140304210032 ACCESSION NUMBER: 0000873303-14-000030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140228 FILED AS OF DATE: 20140304 DATE AS OF CHANGE: 20140304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 7 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 857-242-3700 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 7 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wigzell Hans Lennart Rudolf CENTRAL INDEX KEY: 0001492766 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 14667185 MAIL ADDRESS: STREET 1: OSKAR BAECKSTROMSV.11 CITY: HAGERSTEN STATE: V7 ZIP: 12935 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2014-02-28 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001492766 Wigzell Hans Lennart Rudolf 215 FIRST STREET, SUITE 7 CAMBRIDGE MA 02142 1 0 0 0 Common Stock 2014-02-28 4 A 0 1000.0 0.0 A 3666 D Non-Qualified Stock Option (right to buy) 29.03 2014-02-28 4 A 0 15000.0 0.0 A 2024-02-28 Common Stock 15000 15000 D This is a Restricted Stock Award that will vest at a rate of 25% annually over four years to commence on the first anniversary of the Issuers next annual meeting of stockholders. This option will vest at a rate of 25% annually over four years to commence on the first anniversary of the Issuers next annual meeting of stockholders. By: /s/David Tyronne Howton For: Hans Lennart Rudolf Wigzell 2014-03-04